{
    "nctId": "NCT01847599",
    "briefTitle": "Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib",
    "officialTitle": "Implementation of a Therapeutic Educational Program Applicated to Adherence of Patients Treated by Capecitabine Alone or in Combination With Lapatinib",
    "overallStatus": "TERMINATED",
    "conditions": "Metastatic Breast Cancer, Colorectal Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 65,
    "primaryOutcomeMeasure": "evaluation of the efficacy of the implementation of an educational program on adherence to capecitabine alone or in combination to lapatinib",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Age\\> 18 years\n* histologically confirmed breast cancer or colorectal cancer\n* Patient starting oral treatment : capecitabine alone or in combination with lapatinib (can be included before the first cycle or during the first 2 cycles).\n* Volunteer to participate in the study.\n* ambulatory treated patient\n* Able to read, write and understand French.\n* Subject who accept to use MEMS monitors to automatically compile their drug dosing histories\n* Written informed consent\n\nExclusion Criteria:\n\n* more than 3 metastatic chemotherapies\n* any severe concomitant condition which makes it undesirable for the patient to participate in the study or which would jeopardize adherence with trial protocol",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}